It’s also worth noting that Neuralink is just one of several companies currently working on developing BCI technology. One competitor is Synchron, a company with similar ambitions that has received funding from the likes of Jeff Bezos and Bill Gates. On February 1, Synchron acquired a minority stake in German manufacturer Acquandas.
Can I buy Neuralink stock?
While the company raised $280 million in August 2023, the capital came from private investors and those employed by the company. Currently, there are no definite signs of the intention to go public, so the general public still cannot invest in Neuralink. Neuralink may decide to launch an initial public offering in the future, however it’s widely believed that this is unlikely to occur anytime soon. Interestingly, Alphabet Inc., which was formerly named Google Inc., owns two venture capital firms that participated in the funding. Synchron launched a sign up for google partners in google ads altcoins patient registry in April to prepare for an upcoming large-scale brain implant trial required to apply for US Federal Drug Administration (FDA) medial device approval. In July, the company announced one of the patients implanted with the Synchron brain computer interface was able to use his direct thoughts to control the cursor on the Apple Vision Pro.
Imagine a world where paralysis is reversible, and brain disorders are treatable with cutting-edge technology. That’s the potential of Neuralink, a company developing brain-computer interfaces to unlock human potential. In this blog post, we will guide you through the ins and outs of investing in Neuralink stock, including its current status, financial backers, road to IPO, and alternative investment options. Neuralink is not a publicly traded company, so it can’t be found on any stock exchange at this moment in time.
Is Neuralink Publicly Traded?
Tesla stock was trading at $1,160 per share as of January 4, 2022, and was valued as a $1 trillion company in October 2021. Hiive is a marketplace where accredited investors can buy private companies stocks. Beyond medical use cases, the company also believes these devices could “unlock human potential” by linking our brains with the internet, artificial intelligence, and other technologies. Musk is renowned for relying on his own assets when looking to fund other ventures and companies.
Neuralink opened a patient registry in early 2023 that allowed people who had at least one of a qualifying list of conditions to volunteer for upcoming clinical trials. The first study, dubbed PRIME — Precise Robotically Implanted Brain-Computer Interface — is specifically focused on patients with cervical spinal cord injuries or amyotrophic lateral sclerosis. Elon Musk’s Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers. The company has faced scrutiny over its animal-testing practices, and the US Transportation Department is currently investigating the company. Invest in or calculate the value of your shares in Neuralink or other pre-IPO companies through EquityZen’s platform. Purchase shares of stock from a company that has already invested in Neuralink.
However, via his Twitter account, he posted that he was “not seeking investors” at the time. Nevertheless, in August 2021, Neuralink accepted a round of Series C funding of $205 million led by Vy Capital. Neuralink is not publicly traded but it is still possible for you to invest in it. In the past, Elon Musk has spoken openly about the possibility of allowing investors into the world of Neuralink. The method involves implanting chips called ‘Links’ into the brains of quadriplegics. And, although this is yet to be achieved on humans, the prospect is perking the interest of many investors.
However, some news outlets have speculated that funding could have come from a combination of venture capitalists, or from Musk himself and the Neuralink team. Synchron’s investment win comes as Musk’s Neuralink faces a federal probe into its animal-testing practices that could set it back. Synchron is one of the companies that could potentially benefit from Neuralink’s technology. The company is developing a device that can be implanted into the brain to help people with paralysis regain movement. It’s important to note that investing in venture capital funds is risky, and investors should do their due diligence before investing. These funds typically have high minimum investment requirements, and investors may need to be accredited to participate.
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering «Private Markets for the Public.» It is unlikely that Neuralink will have an IPO soon since it is a private company and majority-owned by Elon Musk.
- The first is if the company has an exit event like an IPO, merger or acquisition.
- If all goes as planned and the company receives approval from the FDA, Neuralink co-founder Elon Musk said that he might be able to start connecting humans and computers sometime in 2022.
- Interestingly, Alphabet Inc., which was formerly named Google Inc., owns two venture capital firms that participated in the funding.
- Neuralink recently experienced a breakthrough with its mind-boggling technology after completing a successful trial on a chimpanzee.
- Tokenized shares “are digital assets that are backed by the actual shares of Neuralink,” according to GlobeNewswire.
Plant-Derived Shelf Life Extension Technology
For those turning towards Neuralink for neuro-stimulating devices, Abbott offers a wide selection of neuromodulation devices. The company’s short-term goal is to treat serious brain diseases, blindness, and disability, while the long-term objectives aim towards human enhancement or transhumanism. Neuralink is based in California and had a workforce of over 300 by 2022. As of December 2023, the neurotech company has the green light for human trials in the U.S. The company achieved a big breakthrough earlier this month when it successfully implanted a device in its first live human subject.
Additionally, investors can explore firms such as Arch Venture Partners, which are known for backing innovative companies in the sector. Given the star power of the founding team, Neuralink has had no problem raising capital from private equity investors and venture capitalists. Tesla may not directly own shares in Neuralink, as the two companies are separate ventures created by the same founder. Google, however, does have direct exposure to Neuralink through its subsidiary investment fund, Google Ventures. As a result, buying GOOGL shares may be the best way to gain indirect exposure to Neuralink for the general public.
Financial Milestones
There are few indications of its IPO anytime soon, but you should still follow the financial news for the latest information. After opting for an investing platform, you should create and verify an account. Historically a manufacturer of drugs, trading tutorials and platform video guides 2021 today, the company mainly operates within the medical devices, diagnostics, and generic medicines sectors.
Additionally, mutual funds such as FBTAX, FBIOX, and FBDIX have holdings in neural engineering companies, including private companies, providing another avenue for investment in this innovative sector. While SpaceX is still a private company, it reportedly reached “an agreement with new and existing investors to sell up to $755 million in stock from company insiders at $560 what are the best cryptocurrency pairs to trade a share” in October 2021. If you’re somehow involved in the company, you could get the opportunity to invest this way soon. Overall, Musk is known to rely on his own assets to fund his other companies.
These 3 listings are from different sellers who have various asking prices and volume offered. Sellers may be current or former employees, venture capitalists, or angel investors. In preparation to buy Neuralink stock, you must first access the stock market by employing a third-party investing platform. In August 2023, Neuralink raised $280 million in a funding campaign led by Peter Thiel’s Founders Fund.
One of the largest benefits was that the Link allowed him to operate his computer and other devices lying down, while he needed assistance for set up and repositioning with prior devices. The next update came during a Spaces event on X on February 19, during which Musk stated that the patient had recovered and was able to move a computer cursor using thought. However, the lack of third-party validation and limited information shared with the public about the trial has raised concerns about transparency among some researchers. In mid-May, Neuralink’s first patient Noland Arbaugh, who is quadriplegic, shared his experiences in his first 100 days with the Neuralink brainchip. Once implanted, the electrodes develop a BCI, stimulating the brain and monitoring activity, and the threads connect to a custom-designed chip that can read data from groups of neurons. In my opinion, the company is unlikely to go public before it has a marketable product and a consistent stream of revenue.
